Skip to content

Clinical trials

Completed Phase 2 Cardiomyopathy, Hypertrophic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Hypertrophic Phase: Phase 2 Status: Completed Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20061
20071
20111
20141
20151
20161
20182
20191
20203

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)6
Bristol-Myers Squibb1
Carelon Research1
Cytokinetics1
Henning Bundgaard1
Manchester University NHS Foundation Trust1
Massachusetts General Hospital1
MyoKardia, Inc.1
Newcastle University1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Hypertrophic18
Arrhythmias, Cardiac1
Cardiomegaly1
Cardiomyopathies1
Cardiovascular Diseases1
Cicatrix1
Coronary Artery Disease1
Coronary Disease1
Fibrosis1
Heart Diseases1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.